Clinical Trials on the Disaster Mental Health

Conditions: Neurodegenerative Diseases; Dementia Interventions: Diagnostic Test: Venepuncture Sponsors: Monash University; Eastern Health; University of Melbourne; Wake Forest University; Deakin University; The Florey Institute of Neuroscience and Mental Health; Invitae Corporation; Redenlab Recruiting

Conditions: Depressive Disorder, Major Interventions: Drug: Psilocybin 25 mg; Drug: Inactive Placebo; Drug: Psilocybin 5 mg; Behavioral: Psychosocial Support Sponsors: Usona Institute Recruiting

Conditions: Social Anxiety Interventions: Behavioral: Self-referred, undirected Internet-based cognitive behavioral therapy for social anxiety; Behavioral: Recommended, undirected Internet-based cognitive behavioral therapy for social anxiety; Behavioral: Recommended, directed Internet-based cognitive behavioral therapy for social anxiety Sponsors: Université de Sherbrooke; Canadian Institutes of Health Research (CIHR) Recruiting

Conditions: Meningomyelocele Interventions: Diagnostic Test: Single Task (Box and Block Test); Diagnostic Test: Single Task (Nine Hole Peg Test); Diagnostic Test: Dual Task (Box and Block Test-Kognitif Task); Diagnostic Test: Dual Task (Nine Hole Peg Test-Kognitif Task); Diagnostic Test: Dual Task (Box and Block Test-Motor Task); Diagnostic Test: Dual Task (Nine Hole Peg Test-Motor Task); Diagnostic Test: ABILHAND-Kids; Diagnostic Test: Functional Mobility Scale (FMS); Diagnostic Test: Myelomeningocele Functional Classification System (MMFC); Diagnostic Test: Modified Mini Mental Test (MMMT) Sponsors: Abant Izzet Baysal University Recruiting

Conditions: Neck Pain; Chronic Pain Interventions: Other: Percutaneous neuromodulation.; Other: Therapeutic Exercise. Sponsors: Universidad de Almeria Recruiting

Conditions: Long COVID; Brain Fog; Cognitive Impairment; Cognitive Dysfunction; Post-Acute COVID-19 Syndrome Interventions: Behavioral: Processing Speed Training; Behavioral: In-lab Instrumental Activities of Daily Living Training; Behavioral: In-lab Brain Health Training; Behavioral: Transfer Package; Behavioral: Follow Up Phone Calls; Behavioral: Vocational Rehabilitation; Behavioral: Peer Mentoring; Behavioral: Reaction Time Training; Procedure: Trans-auricular Vagus Nerve Stimulation: High Intensity; Procedure: Trans-auricular Vagus Nerve Stimulation: Low Intensity Sponsors: University of Alabama at Birmingham; National Institute on Disability, Independent Living, and Rehabilitation Research; Posit Science Recruiting

Conditions: Chronic Migraine Interventions: Drug: Atogepant; Drug: Placebo for Atogepant Sponsors: AbbVie Recruiting

Conditions: Mucopolysaccharidosis II Interventions: Drug: tividenofusp alfa; Drug: idursulfase Sponsors: Denali Therapeutics Inc. Recruiting

Conditions: Rare Disorders; Undiagnosed Disorders; Disorders of Unknown Prevalence; Cornelia De Lange Syndrome; Prenatal Benign Hypophosphatasia; Perinatal Lethal Hypophosphatasia; Odontohypophosphatasia; Adult Hypophosphatasia; Childhood-onset Hypophosphatasia; Infantile Hypophosphatasia; Hypophosphatasia; Kabuki Syndrome; Bohring-Opitz Syndrome; Narcolepsy Without Cataplexy; Narcolepsy-cataplexy; Hypersomnolence Disorder; Idiopathic Hypersomnia Without Long Sleep Time; Idiopathic Hypersomnia With Long Sleep Time; Idiopathic Hypersomnia; Kleine-Levin Syndrome; Kawasaki Disease; Leiomyosarcoma; Leiomyosarcoma of the Corpus Uteri; Leiomyosarcoma of the Cervix Uteri; Leiomyosarcoma of Small Intestine; Acquired Myasthenia Gravis; Addison Disease; Hyperacusis (Hyperacousis); Juvenile Myasthenia Gravis; Transient Neonatal Myasthenia Gravis; Williams Syndrome; Lyme Disease; Myasthenia Gravis; Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome); Isolated Klippel-Feil Syndrome; Frasier Syndrome; Denys-Drash Syndrome; Beckwith-Wiedemann Syndrome; Emanuel Syndrome; Isolated Aniridia; Axenfeld-Rieger Syndrome; Aniridia-intellectual Disability Syndrome; Aniridia - Renal Agenesis - Psychomotor Retardation; Aniridia - Ptosis - Intellectual Disability - Familial Obesity; Aniridia - Cerebellar Ataxia - Intellectual Disability; Aniridia - Absent Patella; Aniridia; Peters Anomaly - Cataract; Peters Anomaly; Potocki-Shaffer Syndrome; Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11; Silver-Russell Syndrome Due to Imprinting Defect of 11p15; Silver-Russell Syndrome Due to 11p15 Microduplication; Syndromic Aniridia; WAGR Syndrome; Wolf-Hirschhorn Syndrome; 4p16.3 Microduplication Syndrome; 4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome; Autosomal Recessive Stickler Syndrome; Stickler Syndrome Type 2; Stickler Syndrome Type 1; Stickler Syndrome; Mucolipidosis Type 4; X-linked Spinocerebellar Ataxia Type 4; X-linked Spinocerebellar Ataxia Type 3; X-linked Intellectual Disability - Ataxia - Apraxia; X-linked Progressive Cerebellar Ataxia; X-linked Non Progressive Cerebellar Ataxia; X-linked Cerebellar Ataxia; Vitamin B12 Deficiency Ataxia; Toxic Exposure Ataxia; Unclassified Autosomal Dominant Spinocerebellar Ataxia; Thyroid Antibody Ataxia; Sporadic Adult-onset Ataxia of Unknown Etiology; Spinocerebellar Ataxia With Oculomotor Anomaly; Spinocerebellar Ataxia With Epilepsy; Spinocerebellar Ataxia With Axonal Neuropathy Type 2; Spinocerebellar Ataxia Type 8; Spinocerebellar Ataxia Type 7; Spinocerebellar Ataxia Type 6; Spinocerebellar Ataxia Type 5; Spinocerebellar Ataxia Type 4; Spinocerebellar Ataxia Type 37; Spinocerebellar Ataxia Type 36; Spinocerebellar Ataxia Type 35; Spinocerebellar Ataxia Type 34; Spinocerebellar Ataxia Type 32; Spinocerebellar Ataxia Type 31; Spinocerebellar Ataxia Type 30; Spinocerebellar Ataxia Type 3; Spinocerebellar Ataxia Type 29; Spinocerebellar Ataxia Type 28; Spinocerebellar Ataxia Type 27; Spinocerebellar Ataxia Type 26; Spinocerebellar Ataxia Type 25; Spinocerebellar Ataxia Type 23; Spinocerebellar Ataxia Type 22; Spinocerebellar Ataxia Type 21; Spinocerebellar Ataxia Type 20; Spinocerebellar Ataxia Type 2; Spinocerebellar Ataxia Type 19/22; Spinocerebellar Ataxia Type 18; Spinocerebellar Ataxia Type 17; Spinocerebellar Ataxia Type 16; Spinocerebellar Ataxia Type 15/16; Spinocerebellar Ataxia Type 14; Spinocerebellar Ataxia Type 13; Spinocerebellar Ataxia Type 12; Spinocerebellar Ataxia Type 11; Spinocerebellar Ataxia Type 10; Spinocerebellar Ataxia Type 1 With Axonal Neuropathy; Spinocerebellar Ataxia Type 1; Spinocerebellar Ataxia - Unknown; Spinocerebellar Ataxia - Dysmorphism; Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature; Spasticity-ataxia-gait Anomalies Syndrome; Spastic Ataxia With Congenital Miosis; Spastic Ataxia - Corneal Dystrophy; Spastic Ataxia; Rare Hereditary Ataxia; Rare Ataxia; Recessive Mitochondrial Ataxia Syndrome; Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature; Posterior Column Ataxia - Retinitis Pigmentosa; Post-Stroke Ataxia; Post-Head Injury Ataxia; Post Vaccination Ataxia; Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract; Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus; Non-hereditary Degenerative Ataxia; Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity; Olivopontocerebellar Atrophy - Deafness; NARP Syndrome; Myoclonus - Cerebellar Ataxia - Deafness; Multiple System Atrophy, Parkinsonian Type; Multiple System Atrophy, Cerebellar Type; Multiple System Atrophy; Maternally-inherited Leigh Syndrome; Machado-Joseph Disease Type 3; Machado-Joseph Disease Type 2; Machado-Joseph Disease Type 1; Leigh Syndrome; Late-onset Ataxia With Dementia; Infection or Post Infection Ataxia; GAD Ataxia; Hereditary Episodic Ataxia; Gliadin/Gluten Ataxia; Friedreich Ataxia; Fragile X-associated Tremor/Ataxia Syndrome; Familial Paroxysmal Ataxia; Exposure to Medications Ataxia; Episodic Ataxia With Slurred Speech; Episodic Ataxia Unknown Type; Episodic Ataxia Type 7; Episodic Ataxia Type 6; Episodic Ataxia Type 5; Episodic Ataxia Type 4; Episodic Ataxia Type 3; Episodic Ataxia Type 1; Epilepsy and/or Ataxia With Myoclonus as Major Feature; Early-onset Spastic Ataxia-neuropathy Syndrome; Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity; Early-onset Cerebellar Ataxia With Retained Tendon Reflexes; Early-onset Ataxia With Dementia; Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia; Dilated Cardiomyopathy With Ataxia; Cataract - Ataxia - Deafness; Cerebellar Ataxia, Cayman Type; Cerebellar Ataxia With Peripheral Neuropathy; Cerebellar Ataxia - Hypogonadism; Cerebellar Ataxia - Ectodermal Dysplasia; Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss; Brain Tumor Ataxia; Brachydactyly - Nystagmus - Cerebellar Ataxia; Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia; Autosomal Recessive Syndromic Cerebellar Ataxia; Autosomal Recessive Spastic Ataxia With Leukoencephalopathy; Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay; Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria; Autosomal Recessive Spastic Ataxia; Autosomal Recessive Metabolic Cerebellar Ataxia; Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine; Autosomal Recessive Ataxia, Beauce Type; Autosomal Recessive Ataxia Due to Ubiquinone Deficiency; Autosomal Recessive Ataxia Due to PEX10 Deficiency; Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia; Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency; Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency; Autosomal Recessive Congenital Cerebellar Ataxia; Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome; Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency; Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency; Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency; Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome; Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity; Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency; Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect; Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion; Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation; Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness; Autosomal Recessive Cerebellar Ataxia; Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly; Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation; Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy; Autosomal Dominant Spastic Ataxia Type 1; Autosomal Dominant Spastic Ataxia; Autosomal Dominant Optic Atrophy; Ataxia-telangiectasia Variant; Ataxia-telangiectasia; Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy; Autosomal Dominant Cerebellar Ataxia Type 4; Autosomal Dominant Cerebellar Ataxia Type 3; Autosomal Dominant Cerebellar Ataxia Type 2; Autosomal Dominant Cerebellar Ataxia Type 1; Autosomal Dominant Cerebellar Ataxia; Ataxia-telangiectasia-like Disorder; Ataxia With Vitamin E Deficiency; Ataxia With Dementia; Ataxia - Oculomotor Apraxia Type 1; Ataxia - Other; Ataxia - Genetic Diagnosis - Unknown; Acquired Ataxia; Adult-onset Autosomal Recessive Cerebellar Ataxia; Alcohol Related Ataxia; Multiple Endocrine Neoplasia; Multiple Endocrine Neoplasia Type II; Multiple Endocrine Neoplasia Type 1; Multiple Endocrine Neoplasia Type 2; Multiple Endocrine Neoplasia, Type IV; Multiple Endocrine Neoplasia, Type 3; Multiple Endocrine Neoplasia (MEN) Syndrome; Multiple Endocrine Neoplasia Type 2B; Multiple Endocrine Neoplasia Type 2A; Atypical Hemolytic Uremic Syndrome; Atypical HUS; Wiedemann-Steiner Syndrome; Breast Implant-Associated Anaplastic Large Cell Lymphoma; Autoimmune/Inflammatory Syndrome Induced by Adjuvants (ASIA); Hemophagocytic Lymphohistiocytosis; Behcet's Disease; Alagille Syndrome; Inclusion Body Myopathy With Early-onset Paget Disease and Frontotemporal Dementia (IBMPFD); Lowe Syndrome; Pitt Hopkins Syndrome; 1p36 Deletion Syndrome; Jansen Type Metaphyseal Chondrodysplasia; Cockayne Syndrome; Chronic Recurrent Multifocal Osteomyelitis; CRMO; Malan Syndrome; Hereditary Sensory and Autonomic Neuropathy Type Ie; VCP Disease; Hypnic Jerking; Sleep Myoclonus; Mollaret Meningitis; Recurrent Viral Meningitis; CRB1; Leber Congenital Amaurosis; Retinitis Pigmentosa; Rare Retinal Disorder; KCNMA1-Channelopathy; Primary Biliary Cirrhosis; ZMYND11; Transient Global Amnesia; Glycogen Storage Disease; Alstrom Syndrome; White Sutton Syndrome; DNM1; EIEE31; Myhre Syndrome; Recurrent Respiratory Papillomatosis; Laryngeal Papillomatosis; Tracheal Papillomatosis; Refsum Disease; Nicolaides Baraitser Syndrome; Leukodystrophy; Tango2; Cauda Equina Syndrome; Rare Gastrointestinal Disorders; Achalasia-Addisonian Syndrome; Achalasia Cardia; Achalasia Icrocephaly Syndrome; Anal Fistula; Congenital Sucrase-Isomaltase Deficiency; Eosinophilic Gastroenteritis; Idiopathic Gastroparesis; Hirschsprung Disease; Rare Inflammatory Bowel Disease; Intestinal Pseudo-Obstruction; Scleroderma; Short Bowel Syndrome; Sacral Agenesis; Sacral Agenesis Syndrome; Caudal Regression; Scheuermann Disease; SMC1A Truncated Mutations (Causing Loss of Gene Function); Cystinosis; Juvenile Nephropathic Cystinosis; Nephropathic Cystinosis; Kennedy Disease; Spinal Bulbar Muscular Atrophy; Warburg Micro Syndrome; Mucolipidoses; Mitochondrial Diseases; Mitochondrial Aminoacyl-tRNA Synthetases; Mt-aaRS Disorders; Hypertrophic Olivary Degeneration; Non-Ketotic Hyperglycinemia; Fish Odor Syndrome; Halitosis; Isolated Congenital Asplenia; Lambert Eaton (LEMS); Biliary Atresia; STAG1 Gene Mutation; Coffin Lowry Syndrome; Borjeson-Forssman-Lehman Syndrome; Blau Syndrome; Arginase 1 Deficiency; HSPB8 Myopathy; Beta-Mannosidosis; TBX4 Syndrome; DHDDS Gene Mutations; MAND-MBD5-Associated Neurodevelopmental Disorder; Constitutional Mismatch Repair Deficiency (CMMRD); SPATA5 Disorder; SPATA5L1 Related Disorder; Acrodysostosis; Multi-systematic Smooth Muscle Dysfunction Syndrome; CRELD1 (Cysteine Rich With EGF Like Domains 1); GNB1 Syndrome; Pyruvate Dehydrogenase Complex Deficiency Disease; Beta Mannosidosis; Kbg Syndrome; Labrune Syndrome; Metachromatic Leukodystrophy (MLD); Moyamoya Disease; OPHN1 Syndrome; Oculopharyngeal Muscular Dystrophy (OPMD); TUBB3 Mutation; WOREE (WWOX-related Epileptic Encephalopathy; SCAR12; Skraban-Deardorff Syndrome; Hereditary Myopathy With Early Respiratory Failure Sponsors: Sanford Health; National Ataxia Foundation; International WAGR Syndrome Association; 4p- Support Group; ML4 Foundation; Cornelia de Lange Syndrome Foundation; Stickler Involved People; Kawasaki Disease Foundation; Klippel-Feil Syndrome Alliance; Klippel-Feil Syndrome Freedom; Hyperacusis Research Limited; Hypersomnia Foundation; Kabuki Syndrome Network; Kleine-Levin Syndrome Foundation; Leiomyosarcoma Direct Research Foundation; Marinesco-Sjogren Syndrome Support Group - NORD; Mucolipidosis Type IV (ML4) Foundation; People with Narcolepsy 4 People with Narcolepsy (PWN4PWN); Soft Bones Incorporated; American Multiple Endocrine Neoplasia Support; Atypical Hemolytic Uremic Syndrome Foundation; All Things Kabuki; Wiedemann-Steiner Syndrome Foundation; Breast Implant Victim Advocates; PROS Foundation; American Behcet's Disease Association; Alstrom United Kingdom; Athymia; Curing Retinal Blindness Foundation; HSAN1E Society; 1p36 Deletion Support and Awareness; The Alagille Syndrome Alliance; Autoinflammatory Alliance; Beyond Batten Disease Foundation; Bohring-Opitz Syndrome Foundation, INC; Cockayne Syndrome Network (Share and Care); CRMO Foundation; Cure VCP Disease,INC; FOD Support; Cystinosis Research Foundation; Global DARE Foundation; Hypnic Jerk-Sleep Myoclonus Support Group; Jansen's Foundation; KCNMA1 Channelopathy International Advocacy Foundation; Kawasaki Disease Foundation Australia; Life with LEMS Foundation; Lowe Syndrome Association; The Malan Syndrome Foundation; Maple Syrup Urine Disease Family Support Group; International Association for Muscle Glycogen Storage Disease (IamGSD); Myhre Syndrome Foundation; DNM1 Families; Nicolaides Baraitser Syndrome (NCBRS) Worldwide Foundation; The PBCers Organization; Pitt Hopkins Research Foundation; Recurrent Meningitis Association; Recurrent Respiratory Papillomatosis Foundation; Remember the Girls; Smith-Kingsmore Syndrome Foundation; SPG Research Foundation; Team Telomere; Transient Global Amnesia Project; The Charlotte & Gwenyth Gray Foundation; The Cute Syndrome Foundation; The Maddi Foundation; White Sutton Syndrome Foundation; Zmynd11 Gene Disorder; Cauda Equina Foundation, Inc; Tango2 Research Foundation; Noah's Hope - Hope4Bridget Foundation; Project Sebastian; SMC1A Epilepsy Foundation; International Foundation for Gastrointestinal Disorders; Endosalpingiosis Foundation, Inc; International Sacral Agenesis/Caudal Regression Association (ISACRA); Scheuermann's Disease Fund; Batten Disease Support and Research Association; Kennedy's Disease Association; Cure Mito Foundation; Warburg Micro Research Foundation; Cure Mucolipidosis; Riaan Research Initiative; CureARS A NJ Nonprofit Corporation; CACNA1H Alliance; IMBS Alliance; SHINE-Syndrome Foundaion; Non- Ketotic Hyperglycinemia (NKH) Crusaders; Hypertrophic Olivary Degeneration Association (HODA); National Organization for Disorders of the Corpus Callosum (NODCC); Team4Travis; Taylor's Tale Foundation; Lambert Eaton (LEMS) Family Association; BARE Inc; STAG1 Gene Foundation; Coffin Lowry Syndrome Foundation; BLFS Incorporate; Aniridia North America; Cure Blau Syndrome Foundation; ARG1D Foundation; CURE HSPB8 Myopathy; International Society of Mannosidosis and Related Disorders; TBX4Life; Cure DHDDS; MANDKind Foundation; Krishnan Family Foundation; SPATA Foundation; Acrodysostosis Support and Research; ACTA2 Alliance; ANA-Aniridia North America; CRELD1 Warriors; GNB1 Advocacy Group; Hope for PDCD Foundation; ISMRD - Beta Mannosidosis; KBG Syndrome Association; The LCC Foundation; MLD Foundation; MSA United Research Consortium; Moyamoya Foundation; OPMD Association; SKDEAS Foundation; The Foundation for Casey's Cure; TUBB3 Foundation; WWOX Foundation Recruiting

Conditions: Migraine Interventions: Behavioral: Brain Education and WELLness with Migraine Group A; Behavioral: Brain Education and WELLness with Migraine Group B Sponsors: Wake Forest University Health Sciences; National Center for Complementary and Integrative Health (NCCIH) Recruiting

Conditions: Stroke; Brain Disease; Vascular Diseases; Cerebrovascular Disorder Sponsors: National Institute of Neurological Disorders and Stroke (NINDS) Recruiting

Conditions: Intellectual Disability Interventions: Device: TSA2 Thermosensory Stimulator Sponsors: National Institutes of Health Clinical Center (CC) Recruiting